Search
Lysozyme
go.drugbank.com/drugs/DB13260InvestigationalMixtures: LYSOBACT 20 MG/10 MG PASTİL, 30 ADET, E-zyme B6 TrocheProducts: NEUFLO TABLET 90 mg, LEFTOSE TABLETS (30 MG)Phenothrin
go.drugbank.com/drugs/DB13717InvestigationalCategories: Compounds used in a research, industrial, or household settingProducts: ANTI-BIT 408 MG/100 ML ŞAMPUAN, 100 ML, ANTI-BIT 408 MG/100 ML ŞAMPUAN, 150 MLNilvadipine
go.drugbank.com/drugs/DB06712ApprovedNilvadipine is a calcium channel blocker (CCB) for the treatment of hypertension.
Products: Tensan retard 8 mg - Kapseln, ESCOR 8MG RETARDKAPSELNRebamipide
go.drugbank.com/drugs/DB11656ApprovedInvestigationalRebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
Categories: Compounds used in a research, industrial, or household settingProducts: MUCOSTA TABLETS 100 MG, บาปิด 100Iocetamic acid
go.drugbank.com/drugs/DB09403ApprovedIocetamic acid is a diagnostic aid (radiopaque medium)
Products: CHOLEBRINE 750 MG (MEDIO DE CONTRASTE RADIOLOGICO)Emtricitabine
go.drugbank.com/drugs/DB00879ApprovedInvestigational[L9019] Emtricitabine was granted FDA approval on 2 July 2003.[L9019] … in high risk adolescents and adults.
Mixtures: TENOHOPE E (EMTRICITABINE 200 MG & TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS), Efatriten 600 mg/200 mg/245 mg FilmtablettenCategories: Antivirals used in combination for the treatment of HIV infectionsValine
go.drugbank.com/drugs/DB00161ApprovedInvestigationalNutraceuticalIt is a precursor in the penicillin biosynthetic pathway.
Mixtures: Aminosyn II 8.5% M In 20% Dextrose (dual Chamber), POLİNUTHREE EN-550 ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ, VE LİPİD EMÜLSİYONU, 2000 MLCysteine
go.drugbank.com/drugs/DB00151ApprovedInvestigationalNutraceuticalA thiol-containing non-essential amino acid that is oxidized to form cystine.
Mixtures: VAMIN 18 EF AMINOASIT SOLÜSYONU, 500 ML, NUMETA PED G16 % E İNFÜZYONLUK EMÜLSİYON, 500 MLProducts: L Cysteine HCl Inj 50mg/mlInterferon alfa-2a
go.drugbank.com/drugs/DB00034ApprovedInvestigationalWithdrawnA type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. … It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
Products: /ml, /ml